School of Medicine

The Washington University Department of Orthopaedic Surgery is hosting young women from St. Louis-area high schools to encourage them to pursue careers in orthopaedic surgery and engineering. The program, called the Perry Initiative, aims to get young women interested in those technical fields where women currently comprise only 7 percent of the professional workforce.

David Levine, a fourth-year medical student, and his wife, Eli, learn that Levine matched in internal medicine at New York University at Match Day March 16. This year, 121 students matched to internships or residencies nationwide and in Canada. 

Washington University School of Medicine in St. Louis has received nearly $4.2 million from the Alzheimer’s Association to accelerate the launch of the first clinical trials to prevent Alzheimer’s disease before symptoms become apparent. John C. Morris, MD, the Harvey A. and Dorismae Hacker Friedman Professor of Neurology, heads the Dominantly Inherited Alzheimer’s Network at the School of Medicine.

Patients and staff in several Barnes-Jewish Hospital resident clinics began moving into the 12-story Center for Outpatient Health at the corner of Forest Park and Euclid avenues March 12. Many of the clinics will be relocated by the end of March, with all moves complete by the end of spring.

Fourth-year students at Washington University School of Medicine, including Kevin Choong and Julietta Chang, learned March 16 where they will continue their medical training. This year, 121 students matched to internships or residencies nationwide and in Canada.

William Julius Wilson, the Lewis P. and Linda L. Geyser University Professor at Harvard University, will present this year’s Chancellor’s Fellows Lecture, “Race and Affirmative Opportunity in the Barack Obama Era” at 11 a.m. Tuesday, March 27, in Graham Chapel for the Assembly Series. His talk is free and open to the public.

A new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells, according to John F. DiPersio, MD, PhD, and his colleagues at Washington University. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.

Postdoctoral researchers will showcase their work at the 8th Annual Postdoc Scientific Symposium at Washington University School of Medicine in St. Louis. The symposium will be held from 11:30 a.m.-5:30 p.m., March 29, 2012, at the Farrell Learning and Teaching Center Atrium and Connor Auditorium.

Batten disease is a rare but fatal neurological disorder that typically strikes young children. Working in mice with the infantile form of the disease, scientists have discovered dramatic improvements in life span and motor function by treating the animals with gene therapy and bone marrow transplantation.

By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, Matthew Walter and their Washington University colleagues have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop early in the disease.